CN1124856C - Pill for treating hemiplegia - Google Patents
Pill for treating hemiplegia Download PDFInfo
- Publication number
- CN1124856C CN1124856C CN98113042A CN98113042A CN1124856C CN 1124856 C CN1124856 C CN 1124856C CN 98113042 A CN98113042 A CN 98113042A CN 98113042 A CN98113042 A CN 98113042A CN 1124856 C CN1124856 C CN 1124856C
- Authority
- CN
- China
- Prior art keywords
- medicine
- apoplexy
- elimination
- radix
- weights
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention is made into pills by processing scorpion, long-noded pit viper, gastrodia tuber, musk, bezoar, angelica and other Chinese herbal medicine according to the combination of the concept of treatment based on overall analyses of patients' conditions of the Chinese traditional medicine with the theory of modern medicine. The pills for treating hemiplegia has the efficacy of blood circulation improvement and blood stasis elimination, evil energy elimination and body resistance strengthening, wind calmness and resuscitation induction, and phlegm and moisture elimination. The present invention has obvious effect on treating and preventing apoplexy and sequela thereof, coronary heart disease, rheumatism, rheumatoid disease, etc., and can effectively reduce or eliminate the threat of symptoms of apoplexy to human health.
Description
Content of the present invention belongs to the preparing technical field of pharmaceuticals, relates to a kind of pure Chinese medicinal preparation that is mainly used in treatment apoplexy and sequela thereof, and its product also can be used for prevention and the treatment to apoplexy prodrome, coronary heart disease, rheumatism and rheumatoid disease.
Apoplexy class disease generally comprises the diseases such as cerebral hemorrhage, cerebral thrombosis, subarachnoid hemorrhage, cerebral vasospasm and facial paralysis in the modern medicine.The apoplexy patient is leaving sequela more through treatment back,, mind unconsciousness unfavorable, facial hemiparalysis etc. as hemiplegia, speech, and it has had a strong impact on patient's the operate as normal and the ability of life, has also brought white elephant to family numbers of patients and even society simultaneously.Method of treatment for apoplexy class disease, more the suggestion of ancient Chinese medicine doctor of all times has and differs, doctor trained in Western medicine medicine commonly used mainly contains persantin, phenobarbitone tablet, trimethadione, codeine injection etc., this class medicine can only play the state of an illness respite effect that makes to this sick curative effect, disease can not get radical cure, and side effect such as drowsiness, erythra, gastrointestinal upset, leukopenia also can appear after taking medicine in the patient; Chinese traditional treatment apoplexy method has acupuncture method, injection treatment method etc., medicine commonly used has nine Rhizoma Et Radix Notopterygii soup, Radix Salviae Miltiorrhizae Injection etc., but its treatment to primary disease also has limitation, exist the course of treatment long, effect is unstable, take and carry many deficiencies such as inconvenience and cure rate be low.
The objective of the invention is at the existing in prior technology defective, by excavating the abundant Chinese medicine resource of motherland, so a kind of prescription science is provided, take and easy to carry, curative effect is high, short treating period and to human body without any side effects being mainly used to treat the medicine of apoplexy and sequela thereof.
Motherland's medical science is for the understanding of apoplexy one disease, be recorded in " interior warp " the earliest, the cause of disease, pathogenesis and the method for treatment of apoplexy there has been research further in succession again to gold dollar epoch Tang and Song Dynasty, modern age, doctor family was in conjunction with modern medicine general knowledge, recognize the generation of apoplexy, conclude not outer empty (deficiency of YIN, the deficiency of vital energy), fire (liver-fire, heart-fire), wind (liver-wind, exogenous wind), expectorant (wind-phlegm, damp-phlegm), gas (QI rising in reverse order), blood (blood stasis) six ends, wherein the hepatic and renal YIN deficiency is that it is basic.Based on to above-mentioned determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs thought and many medical books of all times concentrate on studies and by to oneself concentrated summary of clinical experience for many years, it is the principles of formulating prescriptions of main treatment apoplexy class disease that designer of the present invention proposes with " activating blood circulation to dissipate blood stasis, eliminating pathogenic factor for supporting vital QI, relieve dizziness, high fever, infantile convulsions, epilepsy, etc. and have one's ideas straightened out, eliminate the phlegm dehumidifying ", and develops medicine of the present invention in view of the above.This medicine is to comprise Scorpio; Agkistrodon; Rhizoma Gastrodiae; Moschus; Calculus Bovis; Radix Angelicae Sinensis (wine stir-fry); Rhizoma Chuanxiong; the Radix Astragali (processed with honey); Semen Persicae; Pheretima; Flos Carthami; Bombyx Batryticatus; Herba Cistanches; Radix Dipsaci (salt stir-fry); Arisaema Cum Bile; Pericarpium Citri Reticulatae; Hirudo; Radix Salviae Miltiorrhizae (wine stir-fry); Scolopendra is that the basic recipe and the process of preparing Chinese medicine of process science process at interior all herbal medicines; full side has thrombus; dilute blood; transfer the effect of lively atmosphere blood; to apoplexy and sequela and coronary heart disease; rheumatism; treatment of conditions such as rheumatoid and prevention aspect have fabulous effect; can significantly improve the expression of Ischemic Apoplexy Patients; language and limb function, thus reduce effectively or eliminate of the threat of apoplexy class disease health of people.
The concrete compositing formula that constitutes medicine of the present invention is: the Scorpio that contains 23~50 unit of weights in every part of pharmaceutical formulation; the Agkistrodon of 12~26 unit of weights; the Rhizoma Gastrodiae of 10~25 unit of weights; the Moschus of 2~4 unit of weights; the Calculus Bovis of 2~5 unit of weights; the Radix Angelicae Sinensis of 32~40 unit of weights; the Rhizoma Chuanxiong of 1~30 unit of weight; the Radix Astragali of 35~50 unit of weights; the Semen Persicae of 19~31 unit of weights; the Pheretima of 23~50 unit of weights; the Flos Carthami of 5~17 unit of weights; the Bombyx Batryticatus of 7~18 unit of weights; the Herba Cistanches of 5~20 unit of weights; the Radix Dipsaci of 20~50 unit of weights; the Arisaema Cum Bile of 18~60 unit of weights; the Pericarpium Citri Reticulatae of 15~30 unit of weights; the Hirudo of 9~17 unit of weights; the Scolopendra of the Radix Salviae Miltiorrhizae of 25~30 unit of weights and 10~30 unit of weights.
In the said medicine prescription, Scorpio, Agkistrodon, Rhizoma Gastrodiae Wind-expelling, blood circulation-promoting are monarch drug altogether; Moschus, Calculus Bovis causing resuscitation with aromatic drugs are ministerial drug; Radix Angelicae Sinensis, Rhizoma Chuanxiong, Semen Persicae, Flos Carthami, Radix Salviae Miltiorrhizae, Pheretima, Hirudo, Scolopendra blood circulation promoting and blood stasis dispelling, the auxilliary monarch drug of helping; The expectorant dehumidifying falls in Arisaema Cum Bile, and the Radix Astragali, Herba Cistanches, Radix Dipsaci, Pericarpium Citri Reticulatae are tonified Qi of the kidney, and all medicines share, imitate Bo Lihong, treating both the principal and secondary aspects of a disease is played activating blood circulation to dissipate blood stasis, eliminating pathogenic factor for supporting vital QI altogether, is relieved dizziness, high fever, infantile convulsions, epilepsy, etc. and have one's ideas straightened out, eliminate the phlegm the effect of dehumidifying, can be used for the rehabilitation and the cerebral neural recovery of hemiplegic limb targetedly.
In the production process, after the above-mentioned medical material roguing of respectively distinguishing the flavor of, selected, cleaning, dry in the sun, prescription dosage combination is according to the rules fried in shallow oil juice with a part of medicine, and another part medicine grinds and is fine powder, makes piller then, and its ball size is as the Semen phaseoli radiati grain, and every ball heavily about 0.1 restrains.
The curative effect height of medicine of the present invention, easy to use, the patient only obeys once every day, and with warm water delivery service, drug effect can be kept 18 hours before sleeping evening.The usage of this medicine is relatively unique, and traditional method is not followed in medication, and promptly each consumption is different, and its consumption is due to illness different because of the people.The patient takes medicine generally from nine clothes, should have a rest immediately behind the clothes, forbids activity, and obeying back two hours lesiones can have sense of discomfort, and anosis position is sensation not then; That night, the lesion was not felt if take medicine, and can add two (11) when taking medicine next day; The rest may be inferred, and the lesion has and obviously feels to be appropriate amount to the medication.After this appropriate amount was kept several days, the patient felt the lesion and is not obvious, so dosage is sought a new appropriate amount as stated above.In a word, allow after the each medication of patient the lesion all have obviously is felt as.Annotate in addition, take that this medicine should be avoided drinking and edible pungent raw and cold food, avoid anger and mental burden, contraindication in pregnancy.
Thousands of routine case observations of clinical drug of the present invention and statistics, treatment total effective rate reach 94% or more (treating effective criterion is: conscious, language performance normal, each joint of limbs stretches and bend freely, live and can take care of oneself).
Claims (1)
1, a kind of medicine for the treatment of apoplexy is characterized in that it is to be made by the material medicine of following weight ratio: Scorpio 23~50, Agkistrodon 12~26, Rhizoma Gastrodiae 10~25, Moschus 2~4, Calculus Bovis 2~5, Radix Angelicae Sinensis 32~40, Rhizoma Chuanxiong 1~30, the Radix Astragali 35~50, Semen Persicae 19~31, Pheretima 23~50, Flos Carthami 5~17, Bombyx Batryticatus 7~18, Herba Cistanches 5~20, Radix Dipsaci 20~50, Arisaema Cum Bile 18~60, Pericarpium Citri Reticulatae 15~30, Hirudo 9~17, Radix Salviae Miltiorrhizae 25~30, Scolopendra 10~30.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98113042A CN1124856C (en) | 1998-12-11 | 1998-12-11 | Pill for treating hemiplegia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98113042A CN1124856C (en) | 1998-12-11 | 1998-12-11 | Pill for treating hemiplegia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1256926A CN1256926A (en) | 2000-06-21 |
CN1124856C true CN1124856C (en) | 2003-10-22 |
Family
ID=5222827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98113042A Expired - Fee Related CN1124856C (en) | 1998-12-11 | 1998-12-11 | Pill for treating hemiplegia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1124856C (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1298342C (en) * | 2005-06-22 | 2007-02-07 | 任进才 | Medicine for treating thromboangiitis and its preparing method |
CN101195003B (en) * | 2007-10-23 | 2011-09-14 | 郑林生 | Proprietary Chinese medicine for treating apoplexy and sequela |
CN101675939B (en) * | 2008-09-16 | 2012-04-04 | 谭振花 | Traditional Chinese medicine for treating eye keratitis and preparation method |
CN102526503A (en) * | 2010-12-08 | 2012-07-04 | 吴谋军 | Medicament for treating cerebral infarction and preparation method thereof |
CN103479911B (en) * | 2013-09-11 | 2016-03-02 | 刘爱元 | A kind of Chinese medicine composition for the treatment of apoplexy sequela |
CN105031047A (en) * | 2015-08-12 | 2015-11-11 | 杨大妹 | Method for preparing traditional Chinese medicine for treating cramp |
CN105288241A (en) * | 2015-11-30 | 2016-02-03 | 闻喜县红十字会心脑血管病专科医院 | Traditional Chinese medicine for treating stroke, qi asthenia and blood stasis and preparation method of traditional Chinese medicine |
CN105770487A (en) * | 2016-01-11 | 2016-07-20 | 陕西理工学院 | Traditional Chinese medicine composition for treating cerebral infarction and cerebral hemorrhage sequelae and preparation method thereof |
CN108420985A (en) * | 2018-05-07 | 2018-08-21 | 郭光俊 | A kind of pure Chinese medicine Zhitan preparation |
-
1998
- 1998-12-11 CN CN98113042A patent/CN1124856C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1256926A (en) | 2000-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102670776B (en) | Traditional Chinese medicine composition for curing rheumatism | |
CN102210820A (en) | Chinese medicinal composition for treating leukemia | |
CN102772704A (en) | Medicament for treating geriatric disease | |
CN101327313B (en) | Oral medication for treating epigastric pain | |
CN1124856C (en) | Pill for treating hemiplegia | |
CN103520366A (en) | Traditional Chinese medicine for treating spastic hemiplegia after stroke | |
CN101612347A (en) | Health-care medicinal liquor for treating irregular menstruation | |
CN100512840C (en) | Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis | |
CN102430105A (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
CN103007159B (en) | Chinese medicinal preparation for correcting pancreas islet function | |
CN104524342A (en) | Traditional Chinese medicine preparation for lowering high blood pressure, high blood sugar, high cholesterol, high uric acid and maintaining vigor and preparation method of plaster of traditional Chinese medicine preparation | |
CN104606511B (en) | A kind of Chinese medicine for preventing minimally-invasive treatment Lumbar Disc herniation resection rebound phenomenon | |
CN103142923B (en) | Compound mongolian medicine preparation for treating coronary heart disease | |
CN100534521C (en) | Health wine with functions of resisting fatigue and regulating and enhancing immunity | |
CN104173745A (en) | Nourishing and body-building Mongolian medicine | |
CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
CN108096536A (en) | A kind of Chinese medicine composition for treating hemiplegia | |
CN101244209B (en) | Medicament for preventing or treating cardiovascular and cerebrovascular diseases | |
CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
CN101194997A (en) | Chinese medicine preparation for treating AIDS method for preparing the same | |
CN105194241A (en) | Traditional Chinese medicine preparation for treating neurasthenia and preparation method | |
CN1151833C (en) | Capsule for reducing blood-lipid and preventing thrombosis | |
WO2024138784A1 (en) | Traditional chinese medicine sachet | |
CN100394937C (en) | Medicine for preventing and treating cardiac and cerebral vascular diseases | |
CN113425824A (en) | Tibetan medicine and traditional Chinese medicine combined formula for treating insomnia, medicinal liquor and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |